A carregar...
Adalimumab-induced acute myeloid leukaemia in a patient with Crohn’s disease
We present a patient with Crohn’s disease under treatment with adalimumab who developed acute myeloid leukaemia (AML) with core-binding factor beta gene rearrangement. This case report emphasises the importance of long-term close follow-up of patients receiving adalimumab because of the increased ri...
Na minha lista:
| Publicado no: | BMJ Case Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6366805/ https://ncbi.nlm.nih.gov/pubmed/30718264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-225680 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|